标题
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
作者
关键词
-
出版物
Cancers
Volume 11, Issue 12, Pages 2002
出版商
MDPI AG
发表日期
2019-12-13
DOI
10.3390/cancers11122002
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- STAT1 signaling shields T cells from NK cell-mediated cytotoxicity
- (2019) Yu Hui Kang et al. Nature Communications
- Therapeutic Implication of SOCS1 Modulation in the Treatment of Autoimmunity and Cancer
- (2019) Jatin Sharma et al. Frontiers in Pharmacology
- Fine-Tuning of Type I Interferon Response by STAT3
- (2019) Ming-Hsun Tsai et al. Frontiers in Immunology
- Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes
- (2019) Chunwan Lu et al. Journal for ImmunoTherapy of Cancer
- Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy
- (2019) Rana Shafabakhsh et al. PHARMACOLOGICAL RESEARCH
- Novel activators and small-molecule inhibitors of STAT3 in cancer
- (2019) Lehe Yang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS
- (2019) Digdem Yoyen-Ermis et al. Scientific Reports
- Interferon-gamma induces autophagy-associated apoptosis through induction of cPLA2-dependent mitochondrial ROS generation in colorectal cancer cells
- (2018) Qiu-Shuang Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SHP-1 acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression
- (2018) Liang-Zhi Wen et al. CANCER RESEARCH
- Mutations in the signal transducer and activator of transcription family of genes in cancer
- (2018) Nahid Shahmarvand et al. CANCER SCIENCE
- Revisiting Interleukin-12 as a Cancer Immunotherapy Agent
- (2018) Pedro Berraondo et al. CLINICAL CANCER RESEARCH
- ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
- (2018) John M Wrangle et al. LANCET ONCOLOGY
- IDO expression in breast cancer: an assessment of 281 primary and metastatic cases with comparison to PD-L1
- (2018) Erik A. Dill et al. MODERN PATHOLOGY
- Study on the mechanism of JAK2/STAT3 signaling pathway-mediated inflammatory reaction after cerebral ischemia
- (2018) Yuquan Wu et al. Molecular Medicine Reports
- Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis
- (2018) Jinah Park et al. ONCOGENE
- Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma
- (2018) Li Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IRF9 and unphosphorylated STAT2 cooperate with NF-κB to drive IL6 expression
- (2018) Jing Nan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The revival of CpG oligonucleotide-based cancer immunotherapies
- (2018) Tomasz Adamus et al. Wspolczesna Onkologia-Contemporary Oncology
- Curcumin interacts directly with the Cysteine 259 residue of STAT3 and induces apoptosis in H-Ras transformed human mammary epithelial cells
- (2018) Young-Il Hahn et al. Scientific Reports
- Prospects of IL-2 in Cancer Immunotherapy
- (2018) Hani Choudhry et al. Biomed Research International
- A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses
- (2018) Agata Michalska et al. Frontiers in Immunology
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- Interleukin-1 Beta—A Friend or Foe in Malignancies?
- (2018) Rebekka Bent et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
- (2018) Antoni Ribas et al. Cancer Discovery
- SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
- (2018) Mingxia Zhao et al. Acta Pharmaceutica Sinica B
- The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
- (2018) Ali Masjedi et al. BIOMEDICINE & PHARMACOTHERAPY
- JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians
- (2018) Helena Stabile et al. IMMUNOLOGICAL REVIEWS
- The natural polyphenol curcumin induces apoptosis by suppressing STAT3 signaling in esophageal squamous cell carcinoma
- (2018) Ying Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy
- (2018) Lorenzo Mortara et al. Frontiers in Immunology
- Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
- (2018) Guo-Juan Niu et al. Frontiers in Immunology
- Trial Watch: Toll-like receptor agonists in cancer immunotherapy
- (2018) Melody Smith et al. OncoImmunology
- STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
- (2018) Matthew J. Reilley et al. Journal for ImmunoTherapy of Cancer
- Expression of STAT3 in Prostate Cancer Metastases
- (2017) Nicholas Don-Doncow et al. EUROPEAN UROLOGY
- The molecular basis for differential type I interferon signaling
- (2017) Gideon Schreiber JOURNAL OF BIOLOGICAL CHEMISTRY
- Unphosphorylated STAT1 represses apoptosis in macrophages duringMycobacteriumtuberculosisinfection
- (2017) Kezhen Yao et al. JOURNAL OF CELL SCIENCE
- JAK/STAT disruption induces immuno-deficiency: Rationale for the development of JAK inhibitors as immunosuppressive drugs
- (2017) Isabelle Cornez et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
- (2017) Bernd Groner et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections
- (2017) Wenshi Wang et al. Science Signaling
- MiR-629 promotes human pancreatic cancer progression by targeting FOXO3
- (2017) Haijiao Yan et al. Cell Death & Disease
- Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity
- (2017) Purnima Bhat et al. Cell Death & Disease
- IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
- (2017) Kazuyoshi Takeda et al. Nature Communications
- Cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and JAK3 with therapeutic implications
- (2017) Shuyu D. Li et al. Genome Medicine
- Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections
- (2017) Wenshi Wang et al. Science Signaling
- Neoadjuvant Interferons: Critical for Effective PD-1–Based Immunotherapy in TNBC
- (2017) Natasha K. Brockwell et al. Cancer Immunology Research
- Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation
- (2017) Jingjiao Zhou et al. Cancer Immunology Research
- Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment
- (2017) Mengmeng Jiang et al. Frontiers in Immunology
- STATs in NK-Cells: The Good, the Bad, and the Ugly
- (2017) Dagmar Gotthardt et al. Frontiers in Immunology
- Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis
- (2017) Eva M. Putz et al. OncoImmunology
- Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion
- (2017) Lee A. Albacker et al. PLoS One
- High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia
- (2016) E. I. Andersson et al. BLOOD
- A Breakthrough: Macrophage-Directed Cancer Immunotherapy
- (2016) C. D. Mills et al. CANCER RESEARCH
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- JAK-STAT signaling in cancer: From cytokines to non-coding genome
- (2016) Jan Pencik et al. CYTOKINE
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Curcumin Suppressed Activation of Dendritic Cells via JAK/STAT/SOCS Signal in Mice with Experimental Colitis
- (2016) Hai-Mei Zhao et al. Frontiers in Pharmacology
- The long noncoding RNA CASC2 functions as a competing endogenous RNA by sponging miR-18a in colorectal cancer
- (2016) Guanli Huang et al. Scientific Reports
- The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
- (2015) S J Thomas et al. BRITISH JOURNAL OF CANCER
- Beyond the histone tale: HP1α deregulation in breast cancer epigenetics
- (2015) Johan Vad-Nielsen et al. CANCER BIOLOGY & THERAPY
- Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity
- (2015) Bing Liu et al. Cancer Cell International
- The paradoxical role of IL-10 in immunity and cancer
- (2015) Mark H. Mannino et al. CANCER LETTERS
- STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis
- (2015) Laura M. Jones et al. CANCER RESEARCH
- Interleukin-15: New kid on the block for antitumor combination therapy
- (2015) Johan M.J. Van den Bergh et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Understanding the Mechanisms of Androgen Deprivation Resistance in Prostate Cancer at the Molecular Level
- (2015) Theodoros Karantanos et al. EUROPEAN UROLOGY
- TCR and CD28 activate the transcription factor NF-κB in T-cells via distinct adaptor signaling complexes
- (2015) Youg Raj Thaker et al. IMMUNOLOGY LETTERS
- Constitutive activation of STAT3 in breast cancer cells: A review
- (2015) Kasturi Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
- (2015) Herbert I. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Cish actively silences TCR signaling in CD8 + T cells to maintain tumor tolerance
- (2015) Douglas C. Palmer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1
- (2015) Peter Hsu et al. JOURNAL OF IMMUNOLOGY
- PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer
- (2015) M Puhr et al. ONCOGENE
- NK cells regulating T cell responses: mechanisms and outcome
- (2015) Josh Crouse et al. TRENDS IN IMMUNOLOGY
- ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis
- (2015) M Yang et al. Cell Death & Disease
- Siltuximab (CNTO 328): a promising option for human malignancies
- (2015) Bao-An Chen et al. Drug Design Development and Therapy
- STAT1 deficiency redirects IFN signalling toward suppression of TLR response through a feedback activation of STAT3
- (2015) Hun Sik Kim et al. Scientific Reports
- Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
- (2015) J. Rautela et al. Cancer Immunology Research
- Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy
- (2015) Kristina Iribarren et al. OncoImmunology
- Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis
- (2015) Shuai Zhao et al. PLoS One
- Putting the brakes on mammary tumorigenesis: Loss of STAT1 predisposes to intraepithelial neoplasias
- (2015) Christine Schneckenleithner et al. Oncotarget
- Loss of STAT1 from Mouse Mammary Epithelium Results in an Increased Neu-Induced Tumor Burden
- (2015) Peter J. Klover et al. NEOPLASIA
- High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer
- (2014) Piotr Tymoszuk et al. BMC CANCER
- Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
- (2014) Ho-June Lee et al. CANCER CELL
- IFN-γ regulates survival and function of tumor-induced CD11b+Gr-1highmyeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1
- (2014) José Medina-Echeverz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- New Function of Type I IFN: Induction of Autophagy
- (2014) Hana Schmeisser et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Upregulation of Stat1-HDAC4 confers resistance to etoposide through enhanced multidrug resistance 1 expression in human A549 lung cancer cells
- (2014) CHUTIMA KAEWPIBOON et al. Molecular Medicine Reports
- Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
- (2014) T. Bald et al. Cancer Discovery
- Type I Interferons as Regulators of Human Antigen Presenting Cell Functions
- (2014) Sandra Gessani et al. Toxins
- IL-10: Master Switch from Tumor-Promoting Inflammation to Antitumor Immunity
- (2014) M. Oft Cancer Immunology Research
- STAT3 in Cancer—Friend or Foe?
- (2014) Hai-Feng Zhang et al. Cancers
- Crosstalk between the Type 1 Interferon and Nuclear Factor Kappa B Pathways Confers Resistance to a Lethal Virus Infection
- (2013) Daniel Rubio et al. Cell Host & Microbe
- NF-κB: roles and regulation in different CD4+T-cell subsets
- (2013) Hyunju Oh et al. IMMUNOLOGICAL REVIEWS
- Tumor STAT1 Transcription Factor Activity Enhances Breast Tumor Growth and Immune Suppression Mediated by Myeloid-derived Suppressor Cells
- (2013) Laura M. Hix et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation
- (2013) C. Andrew Stewart et al. JOURNAL OF CLINICAL INVESTIGATION
- STAT inhibitors for cancer therapy
- (2013) Muhammad Furqan et al. Journal of Hematology & Oncology
- TLR agonists: our best frenemy in cancer immunotherapy
- (2013) Sabina Kaczanowska et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer
- (2013) Sarah R. Walker et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- T-helper-1-cell cytokines drive cancer into senescence
- (2013) Heidi Braumüller et al. NATURE
- A new look at T cell receptor signaling to nuclear factor-κB
- (2013) Suman Paul et al. TRENDS IN IMMUNOLOGY
- A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases
- (2013) F Hayakawa et al. Blood Cancer Journal
- CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance
- (2013) Eva Maria Putz et al. Cell Reports
- NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
- (2012) Esther M de Kruijf et al. BMC CANCER
- JAK2/STAT5 Inhibition Circumvents Resistance to PI3K/mTOR Blockade: A Rationale for Cotargeting These Pathways in Metastatic Breast Cancer
- (2012) Adrian Britschgi et al. CANCER CELL
- S1PR1-STAT3 Signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic Sites
- (2012) Jiehui Deng et al. CANCER CELL
- Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells
- (2012) Martina J Schmitt et al. Cell Communication and Signaling
- Molecular Pathways: Interferon/Stat1 Pathway: Role in the Tumor Resistance to Genotoxic Stress and Aggressive Growth
- (2012) N. N. Khodarev et al. CLINICAL CANCER RESEARCH
- Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease
- (2012) Apostolos Kontzias et al. CURRENT OPINION IN PHARMACOLOGY
- Biology and significance of the JAK/STAT signalling pathways
- (2012) Hiu Kiu et al. GROWTH FACTORS
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
- (2012) Stefan Rose-John International Journal of Biological Sciences
- STAT3 mutations are highly specific for large granular lymphocytic leukemia
- (2012) A Fasan et al. LEUKEMIA
- Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
- (2012) Bradley N Bidwell et al. NATURE MEDICINE
- SomaticSTAT3Mutations in Large Granular Lymphocytic Leukemia
- (2012) Hanna L.M. Koskela et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type I interferon response and innate immune sensing of cancer
- (2012) Mercedes B. Fuertes et al. TRENDS IN IMMUNOLOGY
- Silencing of microRNA-122 enhances interferon-α signaling in the liver through regulating SOCS3 promoter methylation
- (2012) Takeshi Yoshikawa et al. Scientific Reports
- IL-15 and Type I Interferon Are Required for Activation of Tumoricidal NK Cells by Virus-Infected Dendritic Cells
- (2011) J. E. Boudreau et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Direct Effects of Type I Interferons on Cells of the Immune System
- (2011) S. Hervas-Stubbs et al. CLINICAL CANCER RESEARCH
- JAKs go nuclear: Emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth
- (2011) Fouad A. Zouein et al. GROWTH FACTORS
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2
- (2011) Malay Mandal et al. NATURE IMMUNOLOGY
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma
- (2010) J.-J. Zhao et al. BLOOD
- IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer
- (2010) Chi-Wen Lo et al. CANCER RESEARCH
- MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the Suppressor of Cytokine Signaling 1 Gene
- (2010) S. Jiang et al. CANCER RESEARCH
- The JAK2 V617F somatic mutation, mortality and cancer risk in the general population
- (2010) C. Nielsen et al. HAEMATOLOGICA
- Functional Crosstalk between Type I and II Interferon through the Regulated Expression of STAT1
- (2010) Daniel J. Gough et al. PLOS BIOLOGY
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
- (2009) Michael Hedvat et al. CANCER CELL
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Reduced Risk of Bone Metastasis for Patients With Breast Cancer Who Use COX-2 Inhibitors
- (2009) Matias E. Valsecchi et al. Clinical Breast Cancer
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases
- (2009) Xiaoyu Hu et al. IMMUNITY
- The contribution of direct TLR signaling to T cell responses
- (2009) Adeeb H. Rahman et al. IMMUNOLOGIC RESEARCH
- Akt-mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt
- (2009) Dong Bai et al. INTERNATIONAL JOURNAL OF CANCER
- Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
- (2009) M. Carlsten et al. JOURNAL OF IMMUNOLOGY
- Interferon Regulatory Factors in Hematopoietic Cell Differentiation and Immune Regulation
- (2009) Angela Battistini JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin
- (2009) Mark A. Dawson et al. NATURE
- Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes
- (2009) H. Cheon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Roles of the NF- B Pathway in Lymphocyte Development and Function
- (2009) S. Gerondakis et al. Cold Spring Harbor Perspectives in Biology
- Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers
- (2008) E. G. Jeong et al. CLINICAL CANCER RESEARCH
- Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
- (2008) A M Krieg ONCOGENE
- An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
- (2008) R. R. Weichselbaum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started